HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

TSLX

Sixth Street Specialty Lending, Inc. (NYSE)

Financial Services — Asset Management

Sixth Street Specialty Lending, Inc. (NYSE: TSLX) is a business development company. The fund provides senior secured loans (first-lien, second-lien, and unitranche), unsecured loans, mezzanine debt, and investments in corporate bonds and equity securities and structured products, non-control structured equity, and common equity with a focus on co-investments for organic growth, acquisitions, market or product expansion, restructuring initiatives, recapitalizations, growth capital, buyout, and refinancing. The fund invests in business services, software & technology, healthcare, energy, consumer & retail, manufacturing, industrials, royalty related businesses, education, and specialty finance. The fund seeks to finance and lending to middle market companies principally located in the United States. The fund invests in companies with enterprise value between $50 million and $1000 million or more and EBITDA between $10 million and $250 million. The debt transaction size is between $15 million and $350 million. The fund invests across the spectrum of the capital structure and can arrange syndicated transactions of up to $500 million and hold sizeable positions within its credits.

None 11 analysts
$17.42
+$0.08 (+0.46%)
Target: $19.80 (13.6%)
Sign in to add TSLX to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$1.66B
P/E Ratio (TTM)15.15
Forward P/E9.58
EPS (TTM)$1.15
Dividend Yield9.69%
Profit Margin25.24%
Revenue Growth-19.70%
ROE6.84%
Debt/Equity116.90
Recommendation None
Analyst Target$19.80
Analysts11
Indexes NYSE

Technical Indicators

RSI (14)57.1
Beta0.64
SMA 20-
SMA 40-
52-Week High$25.17
52-Week Low$16.04
50-Day Avg$17.65
200-Day Avg$20.01
Avg Volume740.2K
Volume10.2K

Performance Analysis

NEUTRAL

TSLX presents a mixed picture with both positive and negative indicators.

~ Trading at 15% of its 52-week range.
+ RSI at 57.1 shows positive momentum.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- Revenue declined 19.7% year-over-year.
+ Healthy profit margin of 25.2%.
~ Wall Street consensus is "none" from 11 analysts.
+ Average analyst target of $19.80 implies 13.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:35 UTC

Back to Screener Export Report